美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

减肥药

1,257.83

+13.801.11%

涨家数：6

跌家数：1

平家数：- -

市盈率：- -

高：1,263.83

开：1,245.45

低：1,245.45

收：1,244.03

数据加载中...

诺和诺德5月28日成交额为5.42亿美元

辉瑞大跌，“一哥”市值腰斩，7家美国药企迎最差一季报！MNC全员焦虑

华尔街见闻

辉瑞5月27日成交额为8.52亿美元

礼来5月27日成交额为27.45亿美元

安进5月27日成交额为8.11亿美元

安进/百济神州CD3/DLL3双抗中国临床研究传捷报，将亮相ASCO

美股异动 | 诺和诺德(NVO.US)涨逾4% 已完成下一代减肥药CagriSema最后一项关键试验

硕迪生物盘中异动早盘急速下挫5.36%

诺和诺德盘中异动股价大涨5.21%

诺和诺德(NVO.US)发布盈利预警丹麦跟随下调经济预测

中国创新药企破纪录！三生制药与辉瑞百亿BD引爆全球双抗赛道

GLP-1之后，诺和诺德的“诺亚方舟”在哪里？

大摩评信诺减肥药自付上限政策：与礼来定价指引相符，不改长期增长潜力

【百济神州宣布塔拉妥单抗中国临床研究取得积极结果】5月26日，据百济神州公众号，该公司今日宣布其与安进公司在中国联合开展的注射用塔拉妥单抗2期临床研究DeLLphi-307已取得积极结果。

百济神州宣布塔拉妥单抗中国临床研究取得积极结果

医药生物：拥抱创新药大时代 PD-1双抗天价DEAL、ASCO摘要公布

中泰证券股份有...

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4599/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"减肥药","latestPrice":1257.8302,"timestamp":1749239999999,"preClose":1244.0306,"halted":0,"volume":51513461,"delay":0,"changeRate":0.011093,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":13.799561,"latestTime":"06-06 16:00:00 EDT","open":1245.4493,"high":1263.8325,"low":1245.4493,"amount":3711906755.507839,"amplitude":0.014777,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1749475800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.690713,"peRate":32.301623,"turnoverRate":0.004869,"increases":6,"decrements":1,"flats":0,"marketCap":1354591922304,"floatMarketCap":1258679594368},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1263.8325,"amplitude":0.014777,"preClose":1244.0306,"low":1245.4493,"pbRate":"9.690713","latestPrice":1257.8302,"volume":51513461,"delay":0,"open":1245.4493,"prevYearClose":1305.0607,"prevWeekClose":1257.8302,"prevMonthClose":1216.6,"prevQuarterClose":1314.3724,"fiveDayClose":1216.6,"twentyDayClose":1196.4727,"sixtyDayClose":1333.0085,"secType":"PLATE","market":"US","turnoverRate":0.004869,"peRate":32.301623,"marketCap":1354591922304,"floatMarketCap":1258679594368,"timestamp":1749239999999,"nameCN":"减肥药"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":6,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2539827432","title":"诺和诺德5月28日成交额为5.42亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539827432","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539827432?lang=zh_cn&edition=fundamental","pubTime":"2025-05-29 11:28","pubTimestamp":1748489336,"startTime":"0","endTime":"0","summary":"美东时间2025年5月28日，诺和诺德成交额为5.42亿美元，成交额较昨日减少17.07%，当日成交量为786.47万股。诺和诺德于2025年5月28日跌2.61%，报68.6美元，该股过去5个交易日涨0.59%，年初至今跌19.18%，过去60日跌22.25%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-28|5.42亿|-17.07%|786.47万|#|2025-05-27|6.53亿|49.31%|925.06万|#|2025-05-23|4.37亿|-10.09%|650.84万|#|2025-05-22|4.86亿|-21.33%|719.23万|#|2025-05-21|6.18亿|-28.30%|898.34万|诺和诺德拥有全球约三分之一的品牌糖尿病治疗市场，是全球领先的糖尿病护理产品供应商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529112901a490b1fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529112901a490b1fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO","BK4585","BK4007","BK4588","IE00BZ1G4Q59.USD","BK4532","LU1093756168.USD","LU1093756325.SGD","IE00BKVL7J92.USD","LU0154236417.USD","BK4599"],"gpt_icon":1},{"id":"2539284957","title":"辉瑞大跌，“一哥”市值腰斩，7家美国药企迎最差一季报！MNC全员焦虑","url":"https://stock-news.laohu8.com/highlight/detail?id=2539284957","media":"华尔街见闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539284957?lang=zh_cn&edition=fundamental","pubTime":"2025-05-29 10:58","pubTimestamp":1748487490,"startTime":"0","endTime":"0","summary":"一季度25家制药巨头里有7家收入同比下降，7家公司全部来自美国，最厉害的是晖致下滑11%，其次辉瑞下滑8%。这一季度除了化解产品“青黄不接”的尴尬局面外，还有如何抵御地缘政治、监管变化、潜在关税及多重外部压力带来的长远困扰。","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/6c7f4678-7acd-4171-b81f-1bd75b491201.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/6c7f4678-7acd-4171-b81f-1bd75b491201.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3748079","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3748079","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"辉瑞大跌，“一哥”市值腰斩，7家美国药企迎最差一季报！MNC全员焦虑","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["LU0306807586.USD","BK4599","LU0225284248.USD","BK4592","LU1894683264.USD","IE00BLSP4452.SGD","LU0234572021.USD","LU1023059063.AUD","PFE","SG9999001176.USD","LU1883839398.USD","LU0058720904.USD","LU0289739699.SGD","LU0321505868.SGD","SG9999011175.SGD","LU1066051498.USD","SG9999002224.SGD","BK4585","LU0122379950.USD","IE000M9KFDE8.USD","LU0306806265.USD","BK4581","LU0985481810.HKD","LU0456855351.SGD","SG9999002232.USD","SGXZ57979304.SGD","BK4534","IE00B19Z3581.USD","BK4588","SG9999001176.SGD","LU0225771236.USD","IE0002270589.USD","LU0321505439.SGD","LU0170899867.USD","IE00BLSP4239.USD","BK4568","BK4550","SG9999003800.SGD","IE00B19Z3B42.SGD","BK4007","IE00BBT3K403.USD","LU1066053197.SGD","LU1894683348.USD","SG9999013999.USD","BK4533","LU0868494617.USD","LU1057294990.SGD"],"gpt_icon":1},{"id":"2538106974","title":"辉瑞5月27日成交额为8.52亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538106974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538106974?lang=zh_cn&edition=fundamental","pubTime":"2025-05-28 11:44","pubTimestamp":1748403873,"startTime":"0","endTime":"0","summary":"美东时间2025年5月27日，辉瑞成交额为8.52亿美元，成交额较昨日增加3.57%，当日成交量为3615.54万股。辉瑞于2025年5月27日涨1.24%，报23.61美元，该股过去5个交易日涨2.65%，年初至今跌7.81%，过去60日跌8.97%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-27|8.52亿|3.57%|3615.54万|#|2025-05-23|8.22亿|-7.29%|3540.54万|#|2025-05-22|8.87亿|-11.16%|3860.28万|#|2025-05-21|9.99亿|-25.33%|4298.47万|#|2025-05-20|13.37亿|85.10%|5704.75万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528114443a6efba3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528114443a6efba3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0306806265.USD","LU0058720904.USD","BK4534","BK4592","BK4599","IE00B19Z3581.USD","SG9999011175.SGD","BK4550","SG9999001176.SGD","BK4581","LU0321505439.SGD","LU0234572021.USD","BK4533","LU0321505868.SGD","IE00B19Z3B42.SGD","SG9999003800.SGD","LU0985481810.HKD","IE00BBT3K403.USD","BK4007","BK4568","IE00BLSP4452.SGD","SGXZ57979304.SGD","PFE","LU1883839398.USD","BK4585","LU1057294990.SGD","SG9999001176.USD","LU0289739699.SGD","SG9999002232.USD","LU0170899867.USD","LU0306807586.USD","BK4588","LU0456855351.SGD","LU0225771236.USD","LU1023059063.AUD","LU0225284248.USD","LU1894683348.USD","LU1066053197.SGD","LU0122379950.USD","LU1066051498.USD","LU0868494617.USD","IE0002270589.USD","IE00BLSP4239.USD","IE000M9KFDE8.USD","SG9999002224.SGD","SG9999013999.USD","LU1894683264.USD"],"gpt_icon":1},{"id":"2538412437","title":"礼来5月27日成交额为27.45亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538412437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538412437?lang=zh_cn&edition=fundamental","pubTime":"2025-05-28 10:44","pubTimestamp":1748400262,"startTime":"0","endTime":"0","summary":"美东时间2025年5月27日，礼来成交额为27.45亿美元，成交额较昨日增加45.99%，当日成交量为379.27万股。礼来于2025年5月27日涨1.61%，报725.22美元，该股过去5个交易日跌3.96%，年初至今跌5.71%，过去60日跌21.07%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-27|27.45亿|45.99%|379.27万|#|2025-05-23|18.80亿|-38.27%|263.57万|#|2025-05-22|30.46亿|2.60%|424.99万|#|2025-05-21|29.68亿|2.35%|406.00万|#|2025-05-20|29.00亿|-5.10%|387.35万|礼来制药公司是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528104430a6efaacc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528104430a6efaacc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGXZ31699556.SGD","LU2237443895.HKD","LU1623119135.USD","LU0006306889.USD","LU2089984988.USD","LU2750360997.AUD","LU0823416689.USD","SG9999014914.USD","LU1093756325.SGD","LU0354030438.USD","LU1983299246.USD","LU1720051108.HKD","SG9999014906.USD","LU0385154629.USD","IE00B4R5TH58.HKD","LU2023250504.SGD","LU2361044949.HKD","SG9999001176.USD","SG9999015945.SGD","LU0203202063.USD","SG9999001176.SGD","LU0256863902.USD","LU1814569148.SGD","LU2237438978.USD","LU2237443622.USD","LU0882574139.USD","LU0786609619.USD","LU0708995401.HKD","SG9999014880.SGD","LU0266013472.USD","LU0417517546.SGD","BK4516","SG9999014898.SGD","LU0689472784.USD","IE00BK4W5L77.USD","BK4599","SG9999017495.SGD","LU1232071149.USD","LU2471134952.CNY","LU1366192091.USD","LU0058720904.USD","SGXZ57979304.SGD","LLY","LU2237443978.SGD","LU0354030511.USD","LU0640476718.USD","LU0456855351.SGD","LU2471134523.USD","LU0122379950.USD","LU1868836757.USD"],"gpt_icon":1},{"id":"2538416034","title":"安进5月27日成交额为8.11亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538416034","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538416034?lang=zh_cn&edition=fundamental","pubTime":"2025-05-28 09:16","pubTimestamp":1748394975,"startTime":"0","endTime":"0","summary":"美东时间2025年5月27日，安进成交额为8.11亿美元，成交额较昨日增加18.12%，当日成交量为291.75万股。安进于2025年5月27日涨2.87%，报279.45美元，该股过去5个交易日涨1.31%，年初至今涨9.04%，过去60日跌8.48%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528091650a48f04ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528091650a48f04ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0002141913.USD","IE00B2B36J28.USD","LU1023059063.AUD","BK4581","LU2242652126.USD","BK4534","BK4588","LU1061106388.HKD","LU0058720904.USD","LU1057294990.SGD","LU1571399168.USD","IE0009355771.USD","SG9999001440.SGD","LU0289739699.SGD","LU2468319806.SGD","IE00BJJMRZ35.SGD","BK4533","LU0320765992.SGD","BK4566","LU0868494617.USD","LU0122379950.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","LU1983299246.USD","AMGN","IE00BFTCPJ56.SGD","LU2089984988.USD","LU2112291526.USD","IE00BJT1NW94.SGD","BK4585","LU2242646821.SGD","BK4599","BK4139"],"gpt_icon":0},{"id":"2538049776","title":"安进/百济神州CD3/DLL3双抗中国临床研究传捷报，将亮相ASCO","url":"https://stock-news.laohu8.com/highlight/detail?id=2538049776","media":"药事纵横","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538049776?lang=zh_cn&edition=fundamental","pubTime":"2025-05-28 06:03","pubTimestamp":1748383406,"startTime":"0","endTime":"0","summary":"5月26日，百济神州与安进公司联合宣布，其靶向DLL3/CD3的双特异性抗体药物塔拉妥单抗在中国开展的2期临床研究DeLLphi-307取得积极结果，拟用于广泛期小细胞肺癌三线及以上治疗，详细数据将在5月30日开幕的ASCO年会上公布。除塔拉妥单抗外，百济神州的PD-1抑制剂替雷利珠单抗、君实生物的特瑞普利单抗均在ES-SCLC一线治疗中取得突破，中位OS超过15个月。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528061830a6ef69b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528061830a6ef69b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1023059063.AUD","BK4581","LU1983299246.USD","LU0889565916.HKD","LU2468319806.SGD","BK4526","BK4533","LU0320765992.SGD","IE00BJJMRZ35.SGD","LU1571399168.USD","IE00B4R5TH58.HKD","AMGN","LU0868494617.USD","BK4599","IE00BFTCPJ56.SGD","BK4534","LU0109394709.USD","LU2112291526.USD","LU2242652126.USD","LU0289739699.SGD","LU2089984988.USD","06160","LU2242646821.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","ONC","BK4566","LU0058720904.USD","SG9999001440.SGD","LU0122379950.USD","IE0002141913.USD","IE0009355771.USD","BK4588","BK4585","LU1057294990.SGD","LU1061106388.HKD"],"gpt_icon":1},{"id":"2538837498","title":"美股异动 | 诺和诺德(NVO.US)涨逾4% 已完成下一代减肥药CagriSema最后一项关键试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2538837498","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538837498?lang=zh_cn&edition=fundamental","pubTime":"2025-05-27 23:12","pubTimestamp":1748358757,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，诺和诺德(NVO.US)涨逾4%，报70.53美元。消息面上，诺和诺德全球总裁兼首席执行官周赋德此前对外表示，在研发领域，诺和诺德完成了下一代肥胖症治疗产品CagriSema的最后一项关键试验，并在美国递交了司美格鲁肽片25 mg的注册申请，这款产品将有望成为肥胖症治疗领域的首个口服GLP-1类药物。不过，需要注意的是，诺和诺德于5月7日下调了2025年的销售增长目标和盈利预期，该公司预计，2025年以当地货币计算的销售额增长将在13%至21%之间，而此前预期为16%至24%；预计今年的营业利润增幅将在16%至24%之间，而此前预期为19%至27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1298326.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NVO","BK4585","BK4007","BK4588","IE00BZ1G4Q59.USD","BK4532","LU1093756168.USD","LU1093756325.SGD","IE00BKVL7J92.USD","LU0154236417.USD","BK4599"],"gpt_icon":0},{"id":"2538046228","title":"硕迪生物盘中异动 早盘急速下挫5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538046228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538046228?lang=zh_cn&edition=fundamental","pubTime":"2025-05-27 22:00","pubTimestamp":1748354410,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日22时00分，硕迪生物股票出现异动，股价急速下跌5.36%。截至发稿，该股报23.24美元/股，成交量14.2363万股，换手率0.25%，振幅6.57%。机构评级方面，在所有14家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.92%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527220010a6ef0b4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527220010a6ef0b4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"2538648584","title":"诺和诺德盘中异动 股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538648584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538648584?lang=zh_cn&edition=fundamental","pubTime":"2025-05-27 21:31","pubTimestamp":1748352666,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日21时31分，诺和诺德股票出现异动，股价快速拉升5.21%。诺和诺德股票所在的制药行业中，整体涨幅为0.54%。诺和诺德公司简介：诺和诺德拥有全球约三分之一的品牌糖尿病治疗市场，是全球领先的糖尿病护理产品供应商。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。消息层面，截至21时31分，《诺和诺德发布盈利预警 丹麦跟随下调经济预测》资讯为影响诺和诺德的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527213106a48e7373&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527213106a48e7373&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","BK4007","BK4588","LU0154236417.USD","LU1093756325.SGD","NVO","BK4599","IE00BKVL7J92.USD","LU1093756168.USD","BK4532","BK4585"],"gpt_icon":1},{"id":"2538653504","title":"诺和诺德(NVO.US)发布盈利预警 丹麦跟随下调经济预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2538653504","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538653504?lang=zh_cn&edition=fundamental","pubTime":"2025-05-27 19:43","pubTimestamp":1748346187,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，丹麦财政监督机构所预测，丹麦出口增长幅度将明显低于此前的预期，部分原因是诺和诺德公司在美国遭遇了挫折。该机构表示，这一变化部分归因于诺和诺德本月早些时候发布的盈利预警，同时还将明年的出口预测从之前预计的增长 3.4%下调至 2%。近年来，随着诺和诺德成为全球最大的制药企业，丹麦就业市场和公共财政也得到了提振。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1298217.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"诺和诺德(NVO.US)发布盈利预警 丹麦跟随下调经济预测","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4532","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4007","IE00BKVL7J92.USD","BK4585","LU1093756168.USD","LU1093756325.SGD","BK4599","NVO","BK4588"],"gpt_icon":1},{"id":"2538819455","title":"中国创新药企破纪录！三生制药与辉瑞百亿BD引爆全球双抗赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2538819455","media":"新浪证券","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538819455?lang=zh_cn&edition=fundamental","pubTime":"2025-05-27 16:39","pubTimestamp":1748335140,"startTime":"0","endTime":"0","summary":"近日，中国创新药企三生制药宣布与跨国药企辉瑞达成一项创纪录的License out协议，总金额最高可达60.5亿美元。这一交易不仅刷新了中国药企单品种出海交易的金额纪录，更标志着中国创新药企在全球双特异性抗体赛道的强势崛起。目前，SSGJ-707已在中国进入III期临床，并获FDA批准开展试验，全球进度位居前列。结语从“中国制造”到“中国智造”，三生制药与辉瑞的百亿级合作，为中国创新药出海写下浓墨重彩的一笔。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527164159a48e109d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527164159a48e109d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0058720904.USD","LU0225284248.USD","BK4599","IE00B19Z3B42.SGD","01530","LU0306807586.USD","LU1066051498.USD","BK4534","LU1894683264.USD","SG9999002232.USD","BK4588","LU0289739699.SGD","IE00BLSP4452.SGD","BK4550","LU1023059063.AUD","PFE","SG9999002224.SGD","SG9999011175.SGD","LU1066053197.SGD","BK4581","IE0002270589.USD","BK4585","BK4533","LU0868494617.USD","LU0306806265.USD","LU1883839398.USD","SG9999013999.USD","LU0456855351.SGD","LU0985481810.HKD","BK4592","IE00B19Z3581.USD","IE00BBT3K403.USD","BK4568","LU0321505868.SGD","SG9999001176.USD","LU0170899867.USD","IE00BLSP4239.USD","LU1894683348.USD","LU0321505439.SGD","LU0234572021.USD","BK4007","SGXZ57979304.SGD","SG9999003800.SGD","LU0225771236.USD","IE000M9KFDE8.USD","LU1057294990.SGD","SG9999001176.SGD","LU0122379950.USD"],"gpt_icon":1},{"id":"2538719487","title":"GLP-1之后，诺和诺德的“诺亚方舟”在哪里？","url":"https://stock-news.laohu8.com/highlight/detail?id=2538719487","media":"药时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538719487?lang=zh_cn&edition=fundamental","pubTime":"2025-05-27 08:05","pubTimestamp":1748304331,"startTime":"0","endTime":"0","summary":"如何摆脱“GLP-1依赖症”，是当下诺和诺德需要回答的问题。信达生物GLP-1R/GCGR双靶点药物玛仕度肽已提交上市申请，恒瑞医药、博瑞医药等15家企业的仿制药进入III期临床，九源基因的“吉优泰”成为首个申报上市的司美格鲁肽生物类似药。FDA也已于近日正式受理诺和诺德口服版减肥药Wegovy的新药申请，用于慢性体重管理。根据诺和诺德发布的公告，FDA预计将于今年第四季度公布审批结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527094955a48d9c06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527094955a48d9c06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","LU1093756325.SGD","BK4599","BK4588","BK4007","GLP","BK4144","NVO","BK4590","BK4585","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4532","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2538177600","title":"大摩评信诺减肥药自付上限政策：与礼来定价指引相符，不改长期增长潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2538177600","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538177600?lang=zh_cn&edition=fundamental","pubTime":"2025-05-26 18:06","pubTimestamp":1748253971,"startTime":"0","endTime":"0","summary":"信诺旗下Evernorth最近宣布了一项新的福利方案，将患者每月使用礼来Zepbound和诺和诺德Wegovy的自付费用上限设定为200美元，并维持其非排他性策略。这一策略与CVS旗下Caremark5月2日宣布的从7月1日起在其全国处方集中将Wegovy列为首选药物的合作计划形成显著差异。这一估值倍数高于行业平均和礼来历史均值，反映其对礼来增长潜力的长期信心。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1297602.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2491049909.HKD","IE00BJLML261.HKD","LU0266013472.USD","LU0109391861.USD","LU0820561909.HKD","LU1069344957.HKD","SG9999015945.SGD","LU0708995401.HKD","SG9999015978.USD","LU2552382058.USD","LU1732799900.SGD","LLY","LU0471298694.HKD","LU2360106947.USD","BK4588","LU1548497426.USD","LU2361044865.SGD","LU0238689110.USD","GB00BDT5M118.USD","LU2471134879.HKD","SG9999015952.SGD","LU0689472784.USD","LU2471134523.USD","LU0225283273.USD","LU1917777945.USD","LU2023250504.SGD","LU2089984988.USD","LU1023059063.AUD","LU0354030438.USD","LU0267386448.USD","BK4581","BK4585","IE00BFTCPJ56.SGD","BK4534","BK4599","LU0640476718.USD","LU2237438978.USD","BK4533","LU1035775433.USD","LU1989772840.SGD","IE00BJT1NW94.SGD","SG9999017495.SGD","LU2237443622.USD","LU0672654240.SGD","LU1280957306.USD","SG9999014880.SGD","LU1989771016.USD","LU2133065610.SGD","LU2357305700.SGD","LU0203201768.USD"],"gpt_icon":1},{"id":"2538144043","title":"【百济神州宣布塔拉妥单抗中国临床研究取得积极结果】5月26日，据百济神州公众号，该公司今日宣布其与安进公司在中国联合开展的注射用塔拉妥单抗2期临床研究DeLLphi-307已取得积极结果。","url":"https://stock-news.laohu8.com/highlight/detail?id=2538144043","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538144043?lang=zh_cn&edition=fundamental","pubTime":"2025-05-26 09:10","pubTimestamp":1748221824,"startTime":"0","endTime":"0","summary":"5月26日，据百济神州公众号，该公司今日宣布其与安进公司在中国联合开展的注射用塔拉妥单抗2期临床研究DeLLphi-307已取得积极结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/26091050651544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0122379950.USD","BK4533","LU1969619763.USD","LU1023059063.AUD","ONC","AMGN","LU0058720904.USD","BK4581","IE00BJT1NW94.SGD","LU0289739699.SGD","LU0320765992.SGD","LU1061106388.HKD","IE00BJJMRZ35.SGD","LU2242652126.USD","BK1161","IE00B4R5TH58.HKD","BK4599","LU2468319806.SGD","SG9999001440.SGD","LU0588546209.SGD","LU2112291526.USD","IE0002141913.USD","BK4526","LU2328871848.SGD","BK4139","LU2242646821.SGD","BK1500","BK4588","LU0889565916.HKD","LU1057294990.SGD","BK0239","BK1583","LU0307460666.USD","LU1983299246.USD","IE00B2B36J28.USD","IE0009355771.USD","BK4585","LU0109394709.USD","BK4534","BK4566","688235","LU1571399168.USD","IE00BFTCPJ56.SGD","06160","LU2089984988.USD","BK1588","LU0868494617.USD"],"gpt_icon":0},{"id":"2538144202","title":"百济神州宣布塔拉妥单抗中国临床研究取得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2538144202","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538144202?lang=zh_cn&edition=fundamental","pubTime":"2025-05-26 09:10","pubTimestamp":1748221816,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["688235","BK0239","LU0889565916.HKD","BK1500","IE00B2B36J28.USD","LU0289739699.SGD","LU0588546209.SGD","IE00BFTCPJ56.SGD","LU2112291526.USD","LU0122379950.USD","LU2328871848.SGD","ONC","LU1061106388.HKD","IE00BJJMRZ35.SGD","LU2242652126.USD","BK4588","BK4534","IE0009355771.USD","BK4526","LU0307460666.USD","BK4566","LU0320765992.SGD","LU1023059063.AUD","LU1057294990.SGD","LU1969619763.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU2089984988.USD","BK4139","BK4581","IE0002141913.USD","LU1983299246.USD","LU0868494617.USD","LU0058720904.USD","AMGN","BK4533","BK1583","IE00BJT1NW94.SGD","LU0109394709.USD","06160","SG9999001440.SGD","BK4585","BK1588","LU1571399168.USD","BK4599","LU2242646821.SGD","BK1161"],"gpt_icon":0},{"id":"2538140135","title":"医药生物：拥抱创新药大时代 PD-1双抗天价DEAL、ASCO摘要公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2538140135","media":"中泰证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538140135?lang=zh_cn&edition=fundamental","pubTime":"2025-05-26 00:00","pubTimestamp":1748188800,"startTime":"0","endTime":"0","summary":"本周沪深300 下跌0.18%，医药生物上涨1.78%，处于31 个一级子行业第1 位。本周医药板块表现亮眼，得益于三生制药与辉瑞就PD-1/VEGF 双抗达成的12.5 亿美元首付款的BD 交易，刷新了国产创新药出海的首付款记录，催化了创新药高昂的投资热情，后续具备BD 预期的创新药个股均呈现出强劲上涨态势；此外本周四晚ASCO 研究摘要公布，国产创新药继续展现亮眼数据成果，进一步催化板块行情。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052609450197655f85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052609450197655f85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1894683264.USD","BK4592","LU0306806265.USD","SG9999002232.USD","LU0321505868.SGD","LU1057294990.SGD","LU0456855351.SGD","IE00B19Z3581.USD","SG9999001176.USD","SG9999013999.USD","BK4588","LU0225284248.USD","IE00BBT3K403.USD","BK4581","BK4023","LU0225771236.USD","BK4550","LU0058720904.USD","BK4585","BK4599","BK4533","SG9999003800.SGD","LU0985481810.HKD","IE0002270589.USD","IE000M9KFDE8.USD","LU0170899867.USD","IE00BLSP4239.USD","LU1169590202.USD","LU0306807586.USD","PFE","LU0289739699.SGD","SG9999001176.SGD","IE00BLSP4452.SGD","LU1066053197.SGD","LU0321505439.SGD","PD","SG9999011175.SGD","SGXZ57979304.SGD","SG9999002224.SGD","LU1894683348.USD","LU1883839398.USD","LU0868494617.USD","BK4568","IE00B19Z3B42.SGD","BK4007","LU0234572021.USD","LU1066051498.USD","BK4534","LU1169589451.USD","LU0122379950.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":56,"code":"91000000","status":"200"}]}}